Le Lézard
Classified in: Health, Science and technology
Subject: PDT

ZeOmega® Achieves Significant Growth and Product Innovation in 2017


PLANO, Texas, Jan. 11, 2018 /PRNewswire/ -- ZeOmega®, a market leader in population health management solutions, had a banner year for growth and product innovation in 2017, highlighted by a sharp uptick in implementations of its flagship platform, Jivatm 6.1.  

HIE-enabled Population Health Management

Various enhancements included in Jiva 6.1 have driven much of this recent growth. Among the most in-demand features are new capabilities that facilitate clinical data integration between electronic health records (EHRs), utilization management solutions, and other sources of clinical and financial information. More specifically, ZeOmega has introduced enhanced support for Consolidated-Clinical Document Architecture (C-CDA) standards, automated rules for deriving insights from EHR data, and methods for enriching care plans with clinical information and patient preferences.

In 2017, ZeOmega also rolled out Jiva Predictive Analytics, a highly accurate predictive analytics solution that leverages social determinants of health to assess and stratify patient risk. Jiva for Medicare Advantage, a new solution, enables the effective management of the Medicare Advantage population while also ensuring that clients no longer need worry about meeting Centers for Medicare and Medicaid Services (CMS) requirements for compliance and audit, and ClicBank, a solution that facilitates clinical content configuration and management, have attracted considerable interest as well.

Nine large health organizations from across the United States, both new and existing ZeOmega clients, completed implementations of Jiva 6.1 in 2017. These implementations spanned Medicare Advantage, Managed Medicaid, hospital systems, commercial health plans, and many other lines of business.

"These organizations recognize the game-changing capabilities Jiva 6.1 brings to the table," says Sam Rangaswamy, Founder and Chief Executive Officer for ZeOmega. "We remain committed not only to honing a solution that makes delivering value-based care possible, but to supporting our clients in making value-based care a reality." 

To accommodate the growth of Jiva 6.1 implementations, ZeOmega has rolled out a new consultant certification program. The program trains and certifies consultants from third-party organizations, giving them the knowledge and skills to help ZeOmega expand its Jiva implementation and support capacity. In 2017 alone, ZeOmega certified more than 100 consultants from 16 organizations.

ZeOmega continues to prioritize reinvesting a sizable share of its revenues in innovation, partnering with its clients to make Jiva better every year. To support this objective, last July, it invited clinical informatics expert Dr. Sivakumaran Raman to join the executive team as its Chief Analytics Officer. Dr. Raman has already made significant contributions to the Jiva platform.     

All ZeOmega's solutions comply with the highest industry standards and best practices, as Jiva's long list of certifications and accreditations attests. In the past year, Jiva 6.1 earned certification from The National Committee for Quality Assurance (NCQA) for five Healthcare Effectiveness Data and Information Set (HEDIS®) 2017 Measures, as well as ONC Health IT 2014 Edition modular certification. ZeOmega itself received full accreditation from the Direct Trusted Agent Accreditation Program (DTAAP) as a Health Information Service Provider (HISP).

Black Book Research ranked Jiva first among best Care Management Workflow Applications in the category "Payer Value Based Health Tools." It also included ZeOmega on its list of Top 50 Disruptive Health IT Companies.

About ZeOmega
Jivatm, the HIE-enabled and powerful population health platform from ZeOmega, delivers high-value, strategic solutions enabling payers and care-delivery organizations to improve individual health and provider performance. With deep domain expertise and a comprehensive understanding of complex population health challenges, ZeOmega serves as a true partner for clients, offering flexible deployment and delivery models that leverage an innovative platform designed to integrate workflow, analytics, content, and communication capabilities. By consistently meeting customer expectations and project benchmarks, ZeOmega has earned a reputation for responsiveness and reliability. For more information, visit www.zeomega.com or call 214-618-9880. Follow ZeOmega on Twitter, LinkedIn, and Facebook.

SOURCE ZeOmega


These press releases may also interest you

at 06:08
ConTemporary Locums, a physician-focused medical staffing company, is ushering in a new era with a bold rebrand: Era Locums. This brand evolution marks a commitment to continued innovation and a deeper connection with the company's physician and...

at 06:05
AIS Healthcare, a leading provider of targeted drug delivery (TDD) and infusion care solutions, is proud to recognize March 25-31 as National Physicians Week. This week and throughout the year, we celebrate the dedication of physicians who selflessly...

at 06:00
The "Liquid Biopsy Markets by Cancer, Usage, Biomarker, Place, & Product With Price and Volume Outlook. Including Executive and Consultant Guides and Customized Forecasting and Analysis 2023-2027" report has been added to  ResearchAndMarkets.com's...

at 05:45
The "Global Proteomic Biomarker Analytics Market Forecasts by Application, Technology, Product, and Place, with Executive & Consultant Guides; Including Customized Forecasting and Analysis" report has been added to  ResearchAndMarkets.com's offering....

at 05:45
The Gross Law Firm issues the following notice to shareholders of InMode Ltd. . Shareholders who purchased shares of INMD during the...

at 05:30
The "Syndromic Multiplex Panels Markets. Strategies and Trends. Forecasts by Syndrome (Respiratory, Sepsis, GI etc.) by Place, by Product and by Country. With Market Analysis and Executive Guides. 2024 to 2028" report has been added to...



News published on and distributed by: